1887

Abstract

ISG15 has recently been reported to possess antiviral properties against viruses, both and . Knock-down of ISG15 gene expression by small interfering RNA followed by alpha interferon (IFN-) treatment in Huh-7 cells resulted in an increased phenotypic sensitivity to IFN-, as determined by measuring hepatitis C virus (HCV) RNA replication inhibition in stably transfected HCV replicon cells and in cells infected with genotype 1a HCVcc (infectious HCV). This IFN--specific effect, which was not observed with IFN-, correlated with an increase in expression of the IFN--inducible genes IFI6, IFITM3, OAS1 and MX1, whereas the expression of the non-IFN--inducible genes PTBP-1 and JAK1 remained unchanged. It has previously been reported that, unlike ISG15 knock-down, increased sensitivity to IFN- after knock-down of USP18 occurs through the prolonged phosphorylation of STAT-1. Combination knock-down of ISG15 and USP18 resulted in a moderate increase in IFN--inducible gene expression compared with single ISG15 or USP18 knock-down. Furthermore, the phenotype of increased gene expression after ISG15 knock-down and IFN- treatment was also observed in non-hepatic cell lines A549 and HeLa. Taken together, these results reveal a novel function for ISG15 in the regulation of the IFN- pathway and its antiviral effect.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.013128-0
2009-12-01
2019-12-15
Loading full text...

Full text loading...

/deliver/fulltext/jgv/90/12/2929.html?itemId=/content/journal/jgv/10.1099/vir.0.013128-0&mimeType=html&fmt=ahah

References

  1. Asahina, Y., Izumi, N., Hirayama, I., Tanaka, T., Sato, M., Yasui, Y., Komatsu, N., Umeda, N., Hosokawa, T. & other authors ( 2008; ). Potential relevance of cytoplasmic viral sensors and related regulators involving innate immunity in antiviral response. Gastroenterology 134, 1396–1405.[CrossRef]
    [Google Scholar]
  2. Asselah, T., Bieche, I., Narguet, S., Sabbagh, A., Laurendeau, I., Ripault, M. P., Boyer, N., Martinot-Peignoux, M., Valla, D. & other authors ( 2008; ). Liver gene expression signature to predict response to pegylated interferon plus ribavirin combination therapy in patients with chronic hepatitis C. Gut 57, 516–524.
    [Google Scholar]
  3. Brem, R., Oraszlan-Szovik, K., Foser, S., Bohrmann, B. & Certa, U. ( 2003; ). Inhibition of proliferation by 1–8U in interferon-α-responsive and non-responsive cell lines. Cell Mol Life Sci 60, 1235–1248.
    [Google Scholar]
  4. Chen, L., Borozan, I., Feld, J., Sun, J., Tannis, L. L., Coltescu, C., Heathcote, J., Edwards, A. M. & McGilvray, I. D. ( 2005; ). Hepatic gene expression discriminates responders and nonresponders in treatment of chronic hepatitis C viral infection. Gastroenterology 128, 1437–1444.[CrossRef]
    [Google Scholar]
  5. Cheney, I. W., Lai, V. C., Zhong, W., Brodhag, T., Dempsey, S., Lim, C., Hong, Z., Lau, J. Y. & Tam, R. C. ( 2002; ). Comparative analysis of anti-hepatitis C virus activity and gene expression mediated by alpha, beta, and gamma interferons. J Virol 76, 11148–11154.[CrossRef]
    [Google Scholar]
  6. D'Cunha, J., Knight, E., Jr, Haas, A. L., Truitt, R. L. & Borden, E. C. ( 1996a; ). Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc Natl Acad Sci U S A 93, 211–215.[CrossRef]
    [Google Scholar]
  7. D'Cunha, J., Ramanujam, S., Wagner, R. J., Witt, P. L., Knight, E., Jr & Borden, E. C. ( 1996b; ). In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. J Immunol 157, 4100–4108.
    [Google Scholar]
  8. Frese, M., Schwarzle, V., Barth, K., Krieger, N., Lohmann, V., Mihm, S., Haller, O. & Bartenschlager, R. ( 2002; ). Interferon-γ inhibits replication of subgenomic and genomic hepatitis C virus RNAs. Hepatology 35, 694–703.[CrossRef]
    [Google Scholar]
  9. Gale, M. & Foy, E. M. ( 2005; ). Evasion of intracellular host defence by hepatitis C virus. Nature 436, 939–945.[CrossRef]
    [Google Scholar]
  10. Gee, P., Chua, P. K., Gevorkyan, J., Klumpp, K., Najera, I., Swinney, D. C. & Deval, J. ( 2008; ). Essential role of the N-terminal domain in the regulation of RIG-I ATPase activity. J Biol Chem 283, 9488–9496.[CrossRef]
    [Google Scholar]
  11. Guerra, S., Caceres, A., Knobeloch, K. P., Horak, I. & Esteban, M. ( 2008; ). Vaccinia virus E3 protein prevents the antiviral action of ISG15. PLoS Pathog 4, e1000096 [CrossRef]
    [Google Scholar]
  12. Haas, A. L., Ahrens, P., Bright, P. M. & Ankel, H. ( 1987; ). Interferon induces a 15-kilodalton protein exhibiting marked homology to ubiquitin. J Biol Chem 262, 11315–11323.
    [Google Scholar]
  13. Hsiang, T. Y., Zhao, C. & Krug, R. M. ( 2009; ). Interferon-induced ISG15 conjugation inhibits influenza A virus gene expression and replication in human cells. J Virol 83, 5971–5977.[CrossRef]
    [Google Scholar]
  14. Itsui, Y., Sakamoto, N., Kurosaki, M., Kanazawa, N., Tanabe, Y., Koyama, T., Takeda, Y., Nakagawa, M., Kakinuma, S. & other authors ( 2006; ). Expressional screening of interferon-stimulated genes for antiviral activity against hepatitis C virus replication. J Viral Hepat 13, 690–700.[CrossRef]
    [Google Scholar]
  15. Jiang, D., Guo, H., Xu, C., Chang, J., Gu, B., Wang, L., Block, T. M. & Guo, J. T. ( 2008; ). Identification of three interferon-inducible cellular enzymes that inhibit the replication of hepatitis C virus. J Virol 82, 1665–1678.[CrossRef]
    [Google Scholar]
  16. Kim, K. I., Yan, M., Malakhova, O., Luo, J. K., Shen, M. F., Zou, W., de la Torre, J. C. & Zhang, D. E. ( 2006; ). Ube1L and protein ISGylation are not essential for alpha/beta interferon signaling. Mol Cell Biol 26, 472–479.[CrossRef]
    [Google Scholar]
  17. Kim, M. J., Hwang, S. Y., Imaizumi, T. & Yoo, J. Y. ( 2008; ). Negative feedback regulation of RIG-I-mediated antiviral signaling by interferon-induced ISG15 conjugation. J Virol 82, 1474–1483.[CrossRef]
    [Google Scholar]
  18. Klumpp, K., Leveque, V., Le Pogam, S., Ma, H., Jiang, W. R., Kang, H., Granycome, C., Singer, M., Laxton, C. & other authors ( 2006; ). The novel nucleoside analog R1479 (4′-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture. J Biol Chem 281, 3793–3799.[CrossRef]
    [Google Scholar]
  19. Lenschow, D. J., Giannakopoulos, N. V., Gunn, L. J., Johnston, C., O'Guin, A. K., Schmidt, R. E., Levine, B. & Virgin, H. W., IV ( 2005; ). Identification of interferon-stimulated gene 15 as an antiviral molecule during Sindbis virus infection in vivo. J Virol 79, 13974–13983.[CrossRef]
    [Google Scholar]
  20. Lenschow, D. J., Lai, C., Frias-Staheli, N., Giannakopoulos, N. V., Lutz, A., Wolff, T., Osiak, A., Levine, B., Schmidt & other authors ( 2007; ). IFN-stimulated gene 15 functions as a critical antiviral molecule against influenza, herpes, and Sindbis viruses. Proc Natl Acad Sci U S A 104, 1371–1376.[CrossRef]
    [Google Scholar]
  21. Liu, M., Li, X. L. & Hassel, B. A. ( 2003; ). Proteasomes modulate conjugation to the ubiquitin-like protein, ISG15. J Biol Chem 278, 1594–1602.[CrossRef]
    [Google Scholar]
  22. Malakhov, M. P., Malakhova, O. A., Kim, K. I., Ritchie, K. J. & Zhang, D. E. ( 2002; ). UBP43 (USP18) specifically removes ISG15 from conjugated proteins. J Biol Chem 277, 9976–9981.[CrossRef]
    [Google Scholar]
  23. Malakhov, M. P., Kim, K. I., Malakhova, O. A., Jacobs, B. S., Borden, E. C. & Zhang, D. E. ( 2003; ). High-throughput immunoblotting. Ubiquitiin-like protein ISG15 modifies key regulators of signal transduction. J Biol Chem 278, 16608–16613.[CrossRef]
    [Google Scholar]
  24. Malakhova, O. A. & Zhang, D. E. ( 2008; ). ISG15 inhibits Nedd4 ubiquitin E3 activity and enhances the innate antiviral response. J Biol Chem 283, 8783–8787.[CrossRef]
    [Google Scholar]
  25. Manns, M. P., Foster, G. R., Rockstroh, J. K., Zeuzem, S., Zoulim, F. & Houghton, M. ( 2007; ). The way forward in HCV treatment – finding the right path. Nat Rev Drug Discov 6, 991–1000.[CrossRef]
    [Google Scholar]
  26. Manthey, C. L., Wang, S. W., Kinney, S. D. & Yao, Z. ( 1998; ). SB202190, a selective inhibitor of p38 mitogen-activated protein kinase, is a powerful regulator of LPS-induced mRNAs in monocytes. J Leukoc Biol 64, 409–417.
    [Google Scholar]
  27. Okumura, A., Lu, G., Pitha-Rowe, I. & Pitha, P. M. ( 2006; ). Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc Natl Acad Sci U S A 103, 1440–1445.[CrossRef]
    [Google Scholar]
  28. Okumura, A., Pitha, P. M. & Harty, R. N. ( 2008; ). ISG15 inhibits Ebola VP40 VLP budding in an L-domain-dependent manner by blocking Nedd4 ligase activity. Proc Natl Acad Sci U S A 105, 3974–3979.[CrossRef]
    [Google Scholar]
  29. Osiak, A., Utermohlen, O., Niendorf, S., Horak, I. & Knobeloch, K. P. ( 2005; ). ISG15, an interferon-stimulated ubiquitin-like protein, is not essential for STAT1 signaling and responses against vesicular stomatitis and lymphocytic choriomeningitis virus. Mol Cell Biol 25, 6338–6345.[CrossRef]
    [Google Scholar]
  30. Randall, R. E. & Goodbourn, S. ( 2008; ). Interferons and viruses: an interplay between induction, signalling, antiviral responses and virus countermeasures. J Gen Virol 89, 1–47.[CrossRef]
    [Google Scholar]
  31. Randall, G., Chen, L., Panis, M., Fischer, A. K., Lindenbach, B. D., Sun, J., Heathcote, J., Rice, C. M., Edwards, A. M. & McGilvray, I. D. ( 2006; ). Silencing of USP18 potentiates the antiviral activity of interferon against hepatitis C virus infection. Gastroenterology 131, 1584–1591.[CrossRef]
    [Google Scholar]
  32. Randall, G., Panis, M., Cooper, J. D., Tellinghuisen, T. L., Sukhodolets, K. E., Pfeffer, S., Landthaler, M., Landgraf, P., Kan, S. & other authors ( 2007; ). Cellular cofactors affecting hepatitis C virus infection and replication. Proc Natl Acad Sci U S A 104, 12884–12889.[CrossRef]
    [Google Scholar]
  33. Recht, M., Borden, E. C. & Knight, E., Jr ( 1991; ). A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma. J Immunol 147, 2617–2623.
    [Google Scholar]
  34. Sarasin-Filipowicz, M., Oakeley, E. J., Duong, F. H., Christen, V., Terracciano, L., Filipowicz, W. & Heim, M. H. ( 2008; ). Interferon signaling and treatment outcome in chronic hepatitis C. Proc Natl Acad Sci U S A 105, 7034–7039.[CrossRef]
    [Google Scholar]
  35. Takeuchi, T., Kobayashi, T., Tamura, S. & Yokosawa, H. ( 2006; ). Negative regulation of protein phosphatase 2Cβ by ISG15 conjugation. FEBS Lett 580, 4521–4526.[CrossRef]
    [Google Scholar]
  36. Wong, J. J., Pung, Y. F., Sze, N. S. & Chin, K. C. ( 2006; ). HERC5 is an IFN-induced HECT-type E3 protein ligase that mediates type I IFN-induced ISGylation of protein targets. Proc Natl Acad Sci U S A 103, 10735–10740.[CrossRef]
    [Google Scholar]
  37. Yi, M., Villanueva, R. A., Thomas, D. L., Wakita, T. & Lemon, S. M. ( 2006; ). Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells. Proc Natl Acad Sci U S A 103, 2310–2315.[CrossRef]
    [Google Scholar]
  38. Yuan, W. & Krug, R. M. ( 2001; ). Influenza B virus NS1 protein inhibits conjugation of the interferon (IFN)-induced ubiquitin-like ISG15 protein. EMBO J 20, 362–371.[CrossRef]
    [Google Scholar]
  39. Zhang, Y., Burke, C. W., Ryman, K. D. & Klimstra, W. B. ( 2007; ). Identification and characterization of interferon-induced proteins that inhibit alphavirus replication. J Virol 81, 11246–11255.[CrossRef]
    [Google Scholar]
  40. Zhao, C., Beaudenon, S. L., Kelley, M. L., Waddell, M. B., Yuan, W., Schulman, B. A., Huibregtse, J. M. & Krug, R. M. ( 2004; ). The UbcH8 ubiquitin E2 enzyme is also the E2 enzyme for ISG15, an IFN-α/β-induced ubiquitin-like protein. Proc Natl Acad Sci U S A 101, 7578–7582.[CrossRef]
    [Google Scholar]
  41. Zhao, C., Denison, C., Huibregtse, J. M., Gygi, S. & Krug, R. M. ( 2005; ). Human ISG15 conjugation targets both IFN-induced and constitutively expressed proteins functioning in diverse cellular pathways. Proc Natl Acad Sci U S A 102, 10200–10205.[CrossRef]
    [Google Scholar]
  42. Zhu, H. & Liu, C. ( 2003; ). Interleukin-1 inhibits hepatitis C virus subgenomic RNA replication by activation of extracellular regulated kinase pathway. J Virol 77, 5493–5498.[CrossRef]
    [Google Scholar]
  43. Zhu, H., Zhao, H., Collins, C. D., Eckenrode, S. E., Run, Q., McIndoe, R. A., Crawford, J. M., Nelson, D. R., She, J. X. & Liu, C. ( 2003; ). Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line. Hepatology 37, 1180–1188.[CrossRef]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.013128-0
Loading
/content/journal/jgv/10.1099/vir.0.013128-0
Loading

Data & Media loading...

Supplements

Induction of IFN- -induced gene expression after ISG15 knock-down and IFN- treatment in non-hepatic cell lines A549 and HeLa [ PDF] (88 KB)

PDF

Primer and probe sequences (5′–3′) for qRT-PCR analysis of gene expression [ PDF] (77 KB)

PDF

Most Cited This Month

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error